| Trial ID: | L1413 |
| Source ID: | NCT00328809
|
| Associated Drug: |
Spironolactone
|
| Title: |
Spironolactone Safety in Dialysis Patients
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Disease|Congestive Heart Failure
|
| Interventions: |
DRUG: spironolactone
|
| Outcome Measures: |
Primary: risk of hyperkalemia, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: State University of New York - Upstate Medical University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-06-30
|
| Completion Date: |
2019-09-24
|
| Results First Posted: |
|
| Last Update Posted: |
2020-10-22
|
| Locations: |
SUNY Upstate Medical University, Syracuse, New York, 13210, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00328809
|
